Vivos Inc.

RDGL ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents — $2.2M $1.6M $1.7M $1.6M $903.7K $20.4K $5.5K
Accounts Receivable $22.3K $10.3K $7.0K $11.0K — — — —
Inventory $57.3K — — — — — — —
Total Current Assets $1.7M $2.2M $1.6M $1.7M $1.6M $937.5K $43.9K $16.5K
Property, Plant & Equipment $102.8K — — — — — — —
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — $14.0K $14.0K $24.0K $70.0K
Total Assets $1.9M $2.2M $1.6M $1.7M $1.6M $937.5K $43.9K $16.5K
Liabilities
Accounts Payable $92.5K $86.2K $245.0K $81.7K $166.9K $361.9K $511.8K $795.1K
Total Current Liabilities $117.9K $86.2K $245.0K $81.7K $166.9K $905.5K $1.5M $958.7K
Long-Term Debt — — — — — — — —
Total Liabilities $206.7K $86.2K $245.0K $81.7K $166.9K $905.5K $1.5M $958.7K
Stockholders' Equity
Retained Earnings $-88.4M $-85.4M $-82.5M $-79.6M $-77.1M $-74.6M $-73.6M $-72.0M
Total Stockholders' Equity $1.7M $2.1M $1.4M $1.7M $1.5M $32.0K $-1.5M $-942.2K
← Newer Page 1 of 2 Older →